“…Because the locus coeruleus is the primary source of noradrenaline in the brain, -receptor blockade implicates this neurotransmitter system in control of glucose uptake and utilization, glycogenolysis, and, perhaps, oxygen consumption during activation and exercise. Astrocytes are known targets of the locus coeruleus, and they have ␣ 1 -, ␣ 2 -,  1 -and  2 -adrenergic receptors linked to different second messenger and signaling pathways that modulate their glucose transport, glycolysis, oxidative metabolism, glycogen synthesis and degradation, glutamate uptake, glutamine hydrolysis, and other activities; in general, these processes are stimulated in cultured astrocytes by receptor agonists, with the specific effects dependent on receptor subtypes and signaling pathways [29,32,33,50,51]. Noradrenergic pathway intervention can cause either a rise or fall in brain glucose utilization in animals, depending on condition (with or without stimulation), brain region, and the agonists or antagonists used to target adrenoceptor subtypes [36,38,40,59,60].…”